Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Reference:EU 2011/C 172/01 - CT-3 11-Jun-2011 Section 7 7.3.1  + (Section 7 7.3.1)
• Reference:EU 2011/C 172/01 - CT-3 11-Jun-2011 Section 7 7.3.2  + (Section 7 7.3.2)
• Reference:EU 2011/C 172/01 - CT-3 11-Jun-2011 Section 7 7.3.3  + (Section 7 7.3.3)
• Reference:USA 21 CFR Part 56 09-Apr-2025 Subpart B  + (Subpart B)
• Reference:USA 21 CFR Part 812 09-Apr-2025 Subpart B  + (Subpart B)
• Reference:USA 45 CFR Part 46 09-Apr-2025 Subpart B  + (Subpart B)
• Reference:USA 21 CFR Part 56 09-Apr-2025 Subpart C  + (Subpart C)
• Reference:USA 45 CFR Part 46 09-Apr-2025 Subpart C  + (Subpart C)
• Reference:USA 21 CFR Part 812 09-Apr-2025 Subpart D  + (Subpart D)
• Reference:USA 21 CFR Part 50 09-Apr-2025 Subpart D  + (Subpart D)
• Reference:USA 45 CFR Part 46 09-Apr-2025 Subpart D  + (Subpart D)
• Reference:USA 45 CFR Part 46 09-Apr-2025 Subpart E  + (Subpart E)
• Reference:USA 21 CFR Part 812 09-Apr-2025 Subpart E  + (Subpart E)
• Reference:USA 21 CFR Part 812 09-Apr-2025 Subpart G  + (Subpart G)
• Reference:GBR Guidance Access to Electronic Health Records by Sponsor representatives in clinical trials 44447 System Security  + (System Security)
• Reference:GBR IRAS - Integrated Research Application System 28-Jan-2025 Templates  + (Templates)
• Reference:USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 V.  + (V.)
• Reference:USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 VI C.  + (VI C.)
• Reference:USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 VI D.  + (VI D.)
• Reference:EU GVP: Module VIII EMA/813938/2011 Rev. 3 (2017) VIII.B.4.3  + (VIII.B.4.3)
• Reference:EU GVP: Module VIII EMA/813938/2011 Rev. 3 (2017) VIII.B.4.3.1  + (VIII.B.4.3.1)
• Reference:EU GVP: Module VIII EMA/813938/2011 Rev. 3 (2017) VIII.B.5  + (VIII.B.5)
• Reference:WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005 WHO Principles of GCP  + (WHO Principles of GCP)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 42  + (§ 42)
• Reference:DEU KPBV - Klinische Prüfung-Bewertungsverfahren-Verordnung 31-Jan-2022 § 10  + (§ 10)

• Reference:DEU MBO - Berufsordnung der Ärzt:innen 11-Jun-2021 § 10 Absatz 3  + (§ 10 Absatz 3)

• Reference:DEU KPBV - Klinische Prüfung-Bewertungsverfahren-Verordnung 31-Jan-2022 § 11  + (§ 11)
• Reference:USA 21 CFR Part 11 09-Apr-2025 § 11.10  + (§ 11.10)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.10 (b) (5)  + (§ 11.10 (b) (5))
• Reference:USA 21 CFR Part 11 09-Apr-2025 § 11.100  + (§ 11.100)
• Reference:USA 21 CFR Part 11 09-Apr-2025 § 11.200  + (§ 11.200)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.24  + (§ 11.24)
• Reference:USA 21 CFR Part 11 09-Apr-2025 § 11.3 (b) (5) ; (b) (7) ; (b) (8)  + (§ 11.3 (b) (5) ; (b) (7) ; (b) (8))
• Reference:USA 21 CFR Part 11 09-Apr-2025 § 11.3 (b) (6)  + (§ 11.3 (b) (6))
• Reference:USA 21 CFR Part 11 09-Apr-2025 § 11.30  + (§ 11.30)
• Reference:USA 21 CFR Part 11 09-Apr-2025 § 11.300  + (§ 11.300)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.4  + (§ 11.4)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.40  + (§ 11.40)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.44  + (§ 11.44)
• Reference:USA 21 CFR Part 11 09-Apr-2025 § 11.50  + (§ 11.50)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.54  + (§ 11.54)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.6  + (§ 11.6)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.64  + (§ 11.64)
• Reference:USA 21 CFR Part 11 09-Apr-2025 § 11.70  + (§ 11.70)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.8  + (§ 11.8)
• Reference:DEU MBO - Berufsordnung der Ärzt:innen 11-Jun-2021 § 15  + (§ 15)
• Reference:USA 45 CFR Part 160 09-Apr-2025 § 164.508  + (§ 164.508)
• Reference:USA 45 CFR Part 160 09-Apr-2025 § 164.512  + (§ 164.512)
• Reference:USA 45 CFR Part 160 09-Apr-2025 § 164.526  + (§ 164.526)
• Reference:USA 45 CFR Part 160 09-Apr-2025 § 164.530  + (§ 164.530)
• Reference:DEU MPAMIV - Medizinprodukte-Anwendermelde- und Informationsverordnung 21-Apr-2021 § 2  + (§ 2)